Set StockTrendNews.com as your Homepage! - Click Here Home     About Us     Subscribe     Contact
 
StockTrendNews (STN) Exclusive:
Enter Symbol or Keywords
x
Vasogen's OPS Ranking of "8" Reiterated by StockDiagnostics.com   Stock Quote: (NCM:VSGN)
10/05/2009  
0.26 0.00 0.00% 0
Vasogen's OPS Ranking of "8" Reiterated by StockDiagnostics.com  
Last Price Change % Chg Volume
Sarasota, FL, October 5, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "8" for Vasogen, Inc. (NASDAQ:VSGN). Vasogen has had an OPS Ranking of "8" for fourteen consecut ... read full story  
Website Address:
Industry:
Most Recent STN Exclusives
x
03/19/2010
T12-NEWS reports that the MedClean's Revenue for its 3 months ended December 31, 2009 Increased by 52.47%
03/19/2010
Ten Year High in EBITDA for BlackRock
03/19/2010
EBITDA Increases 109% for Agilent
03/19/2010
Western Refining's EBITDA Turns Negative for its Twelve Months
03/19/2010
Two Year High in Cash Flow from Operations for Smithfield Foods
03/19/2010
Vina Concha y Toro's Free Cash Flow Turns Positive for its Twelve Months
03/19/2010
OPS Ranking of "2" Reiteration for STMicroelectronics
03/19/2010
EBITDA for Smucker Reaches Fourteen Year High
03/19/2010
EBITDA for Liberty Acquisition Deteriorates more than 1,000%
03/19/2010
StockDiagnostics.com Reiterates Quiksilver's OPS Ranking of "1"
Interactive Chart: VSGN
x
More STN Exclusives for: VSGN
x
10/07/2009
EBITDA for Vasogen Reaches Nine Year High
10/05/2009
Vasogen's OPS Ranking of "8" Reiterated by StockDiagnostics.com
10/05/2009
Vasogen's Free Cash Flow Hits Ten Year High
... more VSGN exclusives
Other News Sources: VSGN
x
10/20/2009
VSGN: Volume Spike; 40% > 20-adsv, Stock -4.24%
10/19/2009
Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger
10/15/2009
VSGN: Q3 EPS (5c) vs (12c) EPS +58% Y/Y
... more VSGN news from other sources
Daily Market Updates
x
03/22/2010
Futures Lower in Premarket Following The House's Passage of Healthcare Overhaul
Stock futures are lower in the premarket following the U.S. House's passage of the healthcare overhaul bill, as investors question and fear the short term impact on the markets. Drug companies and device makers could see a positive impact from the bi ... read full story

30 Day Free Trial - MarketWatch Retirement Weekly

Free 30 Day Trial -MarketWatch Hulbert Interactive

Visit Tradesight



Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com

 
 
 
x


 
x
     
 
©2010 StockTrendNews.com
Disclaimer Terms of Sales Privacy About Us